Clinical Trial Update: Vunakizumab in Adults with Spondyloarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Vunakizumab in adults with spondyloarthritis; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthritis

Drugs mentioned

• Vunakizumab (Vunakizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Spondyloarthritis (SpA) | Phase 4 | Status: NOT_YET_RECRUITING